# Decibel Therapeutics funding: rounds and investors

> Decibel Therapeutics has raised $189M across 3 rounds since 2015. Investors include SR One, Third Rock Ventures and Bessemer Venture Partners.

Source: https://millionrounds.com/company/decibel-therapeutics (Millionrounds; every figure on the page links to its filing or article)

United States · [Series D startup](https://millionrounds.com/companies)

# Who invested in *Decibel Therapeutics*

3 rounds we have observed, with the 14 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech Healthcare

Funding summary Updated 26 Oct 2026

**$189M** raised across 3 rounds since 2015, from 3 sources

**$52M** Series A **$55M** Series C **$82M** Series D

- **Latest round:** Series D, $82M Nov 2020
- **Step-up i:** 1.5×
- **Investors:** 14

See who backed them

## The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2016 2017 2018 2019 2020

**$52M** Series A

**$55M** Series C

**$82M** Series D

- **First round:** Series A, $52M
- **Biggest round:** $82M
- **Usual gap between rounds:** 2.7 years

## The rounds

- **Nov 2020** Series D **$82M** *4 new* *1 returning* [Bessemer Venture Partners](https://millionrounds.com/fund/bessemer-venture-partners) [BlackRock](https://millionrounds.com/fund/blackrock) [Janus Henderson Investors](https://millionrounds.com/fund/janus-henderson-investors) [SR One](https://millionrounds.com/fund/sr-one) [Foresite Capital](https://millionrounds.com/fund/forsite-capital) Source recorded SEC filing: $55M sold, first sale Nov 2020
- **Jun 2018** Series C **$55M** *7 new* *2 returning* [Google Ventures](https://millionrounds.com/fund/gv) [SR One](https://millionrounds.com/fund/sr-one) [Third Rock Ventures](https://millionrounds.com/fund/third-rock-ventures) [Bessemer](https://millionrounds.com/fund/bessemer) [S-Cubed Capital](https://millionrounds.com/fund/s-cubed-capital) [Foresite](https://millionrounds.com/fund/foresite) [Schroder Adveq](https://millionrounds.com/fund/schroder-adveq) [Regeneron Pharmaceuticals](https://millionrounds.com/fund/regeneron-pharmaceuticals) Longevity Reported by FinSMEs
- **Oct 2015** Series A **$52M** *3 new* [SR One](https://millionrounds.com/fund/sr-one) [Third Rock Ventures](https://millionrounds.com/fund/third-rock-ventures) [GlaxoSmithKline](https://millionrounds.com/fund/glaxosmithkline) From a historical funding record SEC filing: $8.0M sold, first sale Oct 2015

## Founders and team

From Decibel Therapeutics's own website and the SEC filings it signed: 17 on the team.

- **Chris Fenimore** Executive Vice President, Finance and Chief Financial Officer
- **Ryan Steinberger** Executive Vice President, Chief Digital & Technology Officer
- **Anthony Pankau** Senior Vice President, Manufacturing Operations
- **Benjamin Yocum** Senior Vice President, Manufacturing Operations
- **Brook Jennings** Senior Vice President, Global Immunology Commercial Business Unit
- **Christine Childrose** Senior Vice President, Human Resources and HR Operations
- **Don Sawyer** Senior Vice President, Global Market Access
- **Evgeniya Makarova** Senior Vice President, IOPS Finance & Business Operations
- **George Poth** Senior Vice President, Real Estate & Facilities Management
- **Justin Holko** Senior Vice President, Global Oncology/Hematology Commercial Business Unit
- **Kevin Clark** Senior Vice President, Global Ophthalmology Commercial Business Unit
- **Matthew Everett** Senior Vice President, Global Procurement
- **Nouhad Husseini** Senior Vice President, Business Development
- **Rajesh Ahuja** Senior Vice President, Quality Assurance and Operations
- **Tikiri Dissanayake** Senior Vice President, IOPS Technical Operations
- **Elisabeth Leiderman** Executive Officer i
- **Laurence Reid** Executive Officer, Director i

On the board, as filed i *Anthony A. Philippakis* *Christine A. Poon* *Neil A. Exter* *Peter A. Thompson*

## Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

**Series A** 2015 **Series C** 2018 **Series D** 2020 [SR One](https://millionrounds.com/fund/sr-one) [Third Rock Ventures](https://millionrounds.com/fund/third-rock-ventures) [Bessemer Venture Partners](https://millionrounds.com/fund/bessemer-venture-partners) [Google Ventures](https://millionrounds.com/fund/gv) [BlackRock](https://millionrounds.com/fund/blackrock) [Janus Henderson Investors](https://millionrounds.com/fund/janus-henderson-investors) [Foresite Capital](https://millionrounds.com/fund/forsite-capital) [Bessemer](https://millionrounds.com/fund/bessemer) [GlaxoSmithKline](https://millionrounds.com/fund/glaxosmithkline) [S-Cubed Capital](https://millionrounds.com/fund/s-cubed-capital)

## Everyone who backed them

[SR One](https://millionrounds.com/fund/sr-one) Corporate VC **3** rounds

[Third Rock Ventures](https://millionrounds.com/fund/third-rock-ventures) VC firm **2** rounds

[Bessemer Venture Partners](https://millionrounds.com/fund/bessemer-venture-partners) VC firm **1** round

[Google Ventures](https://millionrounds.com/fund/gv) Corporate VC **1** round

[BlackRock](https://millionrounds.com/fund/blackrock) Asset manager **1** round

[Janus Henderson Investors](https://millionrounds.com/fund/janus-henderson-investors) Private equity **1** round

[Foresite Capital](https://millionrounds.com/fund/forsite-capital) Private equity **1** round

[Bessemer](https://millionrounds.com/fund/bessemer) VC firm **1** round

[GlaxoSmithKline](https://millionrounds.com/fund/glaxosmithkline) VC firm **1** round

[S-Cubed Capital](https://millionrounds.com/fund/s-cubed-capital) VC firm **1** round

[Foresite](https://millionrounds.com/fund/foresite) VC firm **1** round

[Schroder Adveq](https://millionrounds.com/fund/schroder-adveq) VC firm **1** round

[Regeneron Pharmaceuticals](https://millionrounds.com/fund/regeneron-pharmaceuticals) VC firm **1** round

Longevity no record of our own yet **1** round

Missing a round, or an investor who was in one? [Tell us](https://millionrounds.com/corrections?slug=decibel-therapeutics).

## Quick answers about Decibel Therapeutics

### Who invested in Decibel Therapeutics?

Decibel Therapeutics's investors include SR One, Third Rock Ventures, Bessemer Venture Partners, Google Ventures and BlackRock, and 9 more on record.

### How much has Decibel Therapeutics raised?

Decibel Therapeutics has raised $189M across 3 rounds since 2015.

### When did Decibel Therapeutics last raise?

Decibel Therapeutics's most recent round was a Series D of $82M in Nov 2020.

### What was Decibel Therapeutics's biggest round?

Its most recent round, $82M in Nov 2020, is also its largest on record.

### Who backed Decibel Therapeutics first?

Decibel Therapeutics's first round on record, in Oct 2015, was backed by SR One, Third Rock Ventures and GlaxoSmithKline.

### What stage is Decibel Therapeutics at?

Decibel Therapeutics's latest named round is a Series D, in Nov 2020.

### Where is Decibel Therapeutics based?

Decibel Therapeutics is based in the United States.

## Companies like Decibel Therapeutics

In the same sector, and raised in the last eighteen months.

[**Star Therapeutics** $325M · Oct 2026](https://millionrounds.com/company/star-therapeutics)[**Promaxo** $106M · Oct 2026](https://millionrounds.com/company/promaxo)[**Prolific Machines** $105M · Oct 2026](https://millionrounds.com/company/prolific-machines)[**AI** $18M · Oct 2026](https://millionrounds.com/company/ai)[**Baba** $40M · Oct 2026](https://millionrounds.com/company/baba)[**IMIO** $19M · Oct 2026](https://millionrounds.com/company/imio)

## Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.

Open the investor searchOr these rounds in the app
